Ann: Market Update on China business activities, page-21

Email this afternoon from St8ckhead
Yes, eating bird spit is a thing.
ASX Health Stocks: BPH wants to ramp up bird’s nest sales to China

• BPH Global about to ramp up China business
  BPH Global to expand China business
  
  Health & wellness stock BPH Global (ASX:BP8) rose 20% after flagging a potential ramp up in China.
  The company said its executive directors Matthew Leonard and Frank Cannavo will be in China for a series of commercial meetings and prospective cornerstone investor meetings over a 3-4 week period commencing this week.
  BP8 says the visit represents a major business development and fundraising opportunity as the company works toward reactivating and expanding its bird’s nest business in China.
  China is the world’s main consumer of edible bird’s nests, which are specifically made by swiflets, using strands of solidified saliva. They’re known for their nutiritous qualities and have a high collagen content.
  Earlier in the year, BP8 began conducting a pilot program to trial its channels for the sale of bird’s nest products via China Tobacco’s outlets in Guangzhou, and via social media influencers on Douyin (a version of TikTok).
  Separately, BP8 says its new board has implemented a variety of cost-saving measures, including a reduction in director fees, contractors and excess headcount.
  The savings realised through these efforts will be reinvested in key operational areas of the company’s business.
  BPH Global was formerly called Stemcell United (ASX:SCU), and the BP8 shares began trading in March this year.